company background image
BAYN logo

Bayer XTRA:BAYN Stock Report

Last Price

€26.00

Market Cap

€25.5b

7D

-3.9%

1Y

-48.5%

Updated

23 Jun, 2024

Data

Company Financials +

Bayer Aktiengesellschaft

XTRA:BAYN Stock Report

Market Cap: €25.5b

BAYN Stock Overview

Together its subsidiaries, operates as a life science company worldwide.

BAYN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Bayer Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bayer
Historical stock prices
Current Share Price€26.00
52 Week High€53.80
52 Week Low€24.96
Beta0.95
11 Month Change-5.90%
3 Month Change-3.13%
1 Year Change-48.51%
33 Year Change-49.80%
5 Year Change-57.34%
Change since IPO90.90%

Recent News & Updates

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Jun 11
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

The Market Doesn't Like What It Sees From Bayer Aktiengesellschaft's (ETR:BAYN) Revenues Yet

May 07
The Market Doesn't Like What It Sees From Bayer Aktiengesellschaft's (ETR:BAYN) Revenues Yet

Recent updates

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Jun 11
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

The Market Doesn't Like What It Sees From Bayer Aktiengesellschaft's (ETR:BAYN) Revenues Yet

May 07
The Market Doesn't Like What It Sees From Bayer Aktiengesellschaft's (ETR:BAYN) Revenues Yet

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt In A Risky Way

Jan 18
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt In A Risky Way

Are Investors Undervaluing Bayer Aktiengesellschaft (ETR:BAYN) By 42%?

Dec 27
Are Investors Undervaluing Bayer Aktiengesellschaft (ETR:BAYN) By 42%?

Bayer (ETR:BAYN) Takes On Some Risk With Its Use Of Debt

Oct 15
Bayer (ETR:BAYN) Takes On Some Risk With Its Use Of Debt

Bayer Aktiengesellschaft (ETR:BAYN) Shares Could Be 45% Below Their Intrinsic Value Estimate

Aug 05
Bayer Aktiengesellschaft (ETR:BAYN) Shares Could Be 45% Below Their Intrinsic Value Estimate

Is Bayer (ETR:BAYN) A Risky Investment?

Jun 28
Is Bayer (ETR:BAYN) A Risky Investment?

Bayer (ETR:BAYN) Use Of Debt Could Be Considered Risky

Dec 07
Bayer (ETR:BAYN) Use Of Debt Could Be Considered Risky

Shareholder Returns

BAYNDE PharmaceuticalsDE Market
7D-3.9%-3.2%0.09%
1Y-48.5%-15.7%3.1%

Return vs Industry: BAYN underperformed the German Pharmaceuticals industry which returned -15.7% over the past year.

Return vs Market: BAYN underperformed the German Market which returned 3.1% over the past year.

Price Volatility

Is BAYN's price volatile compared to industry and market?
BAYN volatility
BAYN Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.6%
10% least volatile stocks in DE Market2.5%

Stable Share Price: BAYN has not had significant price volatility in the past 3 months.

Volatility Over Time: BAYN's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
186398,189Bill Andersonwww.bayer.com

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Bayer Aktiengesellschaft Fundamentals Summary

How do Bayer's earnings and revenue compare to its market cap?
BAYN fundamental statistics
Market cap€25.54b
Earnings (TTM)-€3.12b
Revenue (TTM)€47.01b

0.5x

P/S Ratio

-8.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAYN income statement (TTM)
Revenue€47.01b
Cost of Revenue€19.48b
Gross Profit€27.54b
Other Expenses€30.66b
Earnings-€3.12b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 06, 2024

Earnings per share (EPS)-3.17
Gross Margin58.57%
Net Profit Margin-6.63%
Debt/Equity Ratio129.4%

How did BAYN perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

-3%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.